Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000

被引:7
|
作者
Braitstein, P
Yip, B
Heath, KV
Levy, AR
Montaner, JSG
Humphries, K
Kiely, FM
O'Shaughnessy, MV
Hogg, RS
机构
[1] BC Ctr Excellence HIV AIDS, Div Epidemiol & Publ Hlth, Vancouver, BC V6Z 1Y6, Canada
[2] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
[3] St Pauls Hosp, British Columbia Cardiac Registries, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
关键词
cardiovascular disease; antiretroviral drugs; adverse effects; HIV; Canada;
D O I
10.1097/00002030-200309260-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To calculate the rate of interventional cardiac procedures (ICP) among HIV-infected individuals ever treated with antiretroviral therapy (ART) and to describe clinical and sociodemographic characteristics associated with ICP. Methods: Since 1992, ART in British Columbia (BC) has been centrally distributed by the BC Centre for Excellence in HIV/AIDS. The BC Cardiac Registry maintains information regarding all cardiac procedures performed in BC. The two databases were linked to determine the number of HIV-positive individuals on ART who underwent ICP. Age-adjusted analyses were conducted using direct standardization, and linear regression to test for trend over time. Logistic regression was used to identify patient and treatment characteristics independently associated with having an interventional cardiac procedure. Results: Of the 5082 individuals who have ever received ART, 63 (< 1 %) were captured in the Cardiac Registry. There were 97 events: 70 (72%) since 1999. The age-adjusted event rate per 1000 HIV-positive individuals on ART increased significantly over time (P= 0.015) whereas that for the general BC population did not increase over time (P=0.191). In multivariate analysis, age at baseline per 10 year increase [adjusted odds ratio (AOR) 2.5; 95% confidence interval (Cl), 1.8-3.2), and months on ART (AOR 1.3; 95% Cl, 1.1 - 1.4) remained significant. Conclusions: The rate of ICP among HIV-positive individuals on ART appears to be increasing; in addition, the duration of time on ART is independently associated with ICP after adjustment for patient demographic characteristics. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2071 / 2075
页数:5
相关论文
共 50 条
  • [1] Incidence of pregnancies among African HIV-infected women, Abidjan, 1995-2000
    Desgrées-du-Loû, A
    Msellati, P
    Viho, I
    Yao, A
    Yapi, D
    Kassi, P
    Welffens-Ekra, C
    Mandelbrot, L
    Dabis, F
    [J]. AIDS, 2001, 15 (17) : 2327 - 2330
  • [2] Causes of death in HIV-infected French drug users, 1995-2000
    Lewden, C
    Bonnet, F
    Bevilacqua, S
    Heripret, L
    May, T
    Morlat, P
    Jougla, E
    Dabis, F
    Chêne, G
    Salmon, D
    [J]. ANNALES DE MEDECINE INTERNE, 2002, 153 : S4 - S10
  • [3] Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
    Hogg, RS
    Heath, KV
    Yip, B
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 450 - 454
  • [4] Prescription medication misuse among HIV-infected individuals taking antiretroviral therapy
    Newville, Howard
    Roley, Jason
    Sorensen, James L.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 48 (01) : 56 - 61
  • [5] Antiretroviral resistance and neuropsychological performance among HIV-infected individuals
    Hightower, G. K.
    Letendre, S. L.
    Cachay, E. R.
    Cherner, M.
    Gibson, S.
    Ellis, R.
    Richman, D. D.
    Ignacio, C. C.
    Smith, D. M.
    [J]. ANTIVIRAL THERAPY, 2007, 12 : S119 - S119
  • [6] Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals
    Lucas, Gregory M.
    [J]. LIFE SCIENCES, 2011, 88 (21-22) : 948 - 952
  • [7] Distress Tolerance and Use of Antiretroviral Therapy Among HIV-Infected Individuals in Substance Abuse Treatment
    Magidson, Jessica F.
    Seitz-Brown, C. J.
    Listhaus, Alyson
    Lindberg, Briana
    Anderson, Katelyn E.
    Daughters, Stacey B.
    [J]. AIDS PATIENT CARE AND STDS, 2013, 27 (09) : 518 - 523
  • [8] Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
    Helleberg, Marie
    May, Margaret T.
    Ingle, Suzanne M.
    Dabis, Francois
    Reiss, Peter
    Faetkenheuer, Gerd
    Costagliola, Dominique
    d'Arminio, Antonella
    Cavassini, Matthias
    Smith, Colette
    Justice, Amy C.
    Gill, John
    Sterne, Jonathan A. C.
    Obel, Niels
    [J]. AIDS, 2015, 29 (02) : 221 - 229
  • [9] Antiretroviral resistance and neuropsychological performance among HIV-infected individuals.
    Hightower, G. K.
    Letendre, S. L.
    Cachay, E. R.
    Cherner, M.
    Gibson, S.
    Ellis, R.
    Richman, D. D.
    Ignacio, C. C.
    Smith, D. M.
    [J]. ANTIVIRAL THERAPY, 2007, 12 (05) : S119 - S119
  • [10] Audiological and electrophysiological alterations in HIV-infected individuals subjected or not to antiretroviral therapy
    Matas, Carla Gentile
    Samelli, Alessandra Giannella
    Leite Magliaro, Fernanda Cristina
    Segurado, Aluisio
    [J]. BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2018, 84 (05) : 574 - 582